Johannes Stein

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Reply to Schwartzmann and Silvestri's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-274.

Reply to Schwartzmann and Silvestri's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-274.

Journal: European urology focus

Published: June 19, 2026

Reply to Emre Karabay's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-74.

Reply to Emre Karabay's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-74.

Journal: European urology focus

Published: May 22, 2026

WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms.

WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms.

Journal: European urology focus

Published: November 11, 2025

High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma.

High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 22, 2024

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.

Journal: BMC urology

Published: January 28, 2024

Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.

Ring Finger Protein 34 (RNF34) as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.

Journal: Cureus

Published: January 26, 2024

Delayed symptomatic renal arteriovenous fistula in a 24 years old male following renal biopsy.

Delayed symptomatic renal arteriovenous fistula in a 24 years old male following renal biopsy.

Journal: Urology case reports

Published: January 23, 2024

Urology consultants versus large language models: Potentials and hazards for medical advice in urology.

Urology consultants versus large language models: Potentials and hazards for medical advice in urology.

Journal: BJUI compass

Published: January 12, 2024

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

Journal: Journal of cancer research and clinical oncology

Published: August 23, 2023

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers.

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers.

Journal: Cancers

Published: February 05, 2023

Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.

Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.

Journal: European urology

Published: November 20, 2022

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis.

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis.

Journal: Biomedicines

Published: November 14, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026